Current standards and standards applicable to risk management
Quality risk management for manufacturing of pharmaceutical products - Concept and regulations

Add to my library

PHA3050 V1 Article

Current standards and standards applicable to risk management


Quality risk management for manufacturing of pharmaceutical products - Concept and regulations

Authors : Mélisande BERNARD, Hassane SADOU YAYE, Jean-Jacques HOURI, Bernard DO

Publication date: December 10, 2015 | Lire en français

Add to my library Add to my library

Logo Techniques de l'Ingenieur You do not have access to this resource.
Request your free trial access! Free trial

Already subscribed?

2. Current standards and standards applicable to risk management

  • In the pharmaceutical industry, risk management has become a regulatory obligation and one of the cornerstones of a company's quality policy.

    From the point of view of GMP, only quality risk management is concerned, i.e. risks associated with the quality, safety and efficacy of medicines. Nevertheless, companies that apply these risk management approaches in areas other than quality may be able to provide answers that are admissible during inspections.

    In response to the new FDA initiative , the ICH published the Q9 Quality Risk Management guide – QRM in 2005. This guide was reproduced as a Guidance...

You do not have access to this resource.
Logo Techniques de l'Ingenieur

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource. Click here to request your free trial access!

Already subscribed?


Article included in this offer

"Drugs and pharmaceuticals"

( 125 articles )

Complete knowledge base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

View offer details

Dans les ressources documentaires

Chiralité et médicaments

Cet article a choisi de mettre en lumière l’importance de l’énantiométrie et de l’isomérie géométrique da...

Traçabilité des produits pharmaceutiques en milieu hospitalier

La traçabilité des produits pharmaceutiques en milieu hospitalier est devenue une exigence réglementaire ...

Nanoparticules et médicaments

Dans la littérature, de plus en plus de stratégies thérapeutiques font appel à l’utilisation de nanoparti...

Réglementation des compléments alimentaires

Le dynamique marché des compléments alimentaires est porté par la quête du bien-être et du mieux vivre. ...

WhitePaper VLEP et exposition aux produits chimiques
19 October 2016
VLEP et exposition aux produits chimiques

Découvrez dans ce livre blanc comment les Valeurs Limites d’Exposition Professionnelle (VLEP) sont déterminées et comment optimiser le mesurage de l’exposition ...

Tous les livres blancs
Article La France rapatrie la production de colchicine
24 June 2026
La France rapatrie la production de colchicine

La relocalisation de certains médicaments rappelle que l’innovation n’est pas le seul enjeu de l’industrie pharmaceutique. Dans le cas de la colchicine, la cont...

Toutes les actualités
Contact us